What does CUSIP 04280A100 represent in this 13F holders report?

CUSIP 04280A100 is the security identifier for ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in Q1 2020?

228 institutional investors reported ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q1 2020 13F Holders as of 31 Mar 2020

Security type / class: Equity / Common Stock
Total 13F shares: 65,790,124
Total 13F value: $1,891,626,404
Share change: +1,268,201
Put/Call ratio: 100%
SEC-reported price per share: $28.77
Number of holders: 228
Value change: -$65,617,767
Number of buys: 111
Number of sells: 170
Shares outstanding: 140,947,086

Security key

04280A100

Report period

Q1 2020

Institutions

228

Top holders

ARWR full security history Ownership snapshot Full 13F holder table ARROWHEAD PHARMACEUTICALS, INC. SEC filings ARROWHEAD PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BlackRock Finance, Inc.

Disclosed value leader

BlackRock Finance, Inc.

Comparable rows

15/15

Latest evidence

31 Dec 2019

13F Lead comparable stake: 8.8% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 8.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.

Comparable ownership Top 5

BlackRock Finance, Inc. 8.8%

VANGUARD GROUP INC 7%

STATE STREET CORP 2.9%

Invesco Ltd. 2.3%

Johnson & Johnson Innovation - JJ... 2.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock Finance, Inc.	13F Company 13F	8.8%	$784,054,000 12,360,958 shares	—	31 Dec 2019
VANGUARD GROUP INC	13F Company 13F	7%	$621,455,000 9,797,507 shares	—	31 Dec 2019
STATE STREET CORP	13F Company 13F	2.9%	$261,615,000 4,124,470 shares	—	31 Dec 2019
Invesco Ltd.	13F Company 13F	2.3%	$208,707,000 3,290,359 shares	—	31 Dec 2019
Johnson & Johnson Innovation - JJDC, Inc.	13F Company 13F	2.3%	$206,837,000 3,260,869 shares	—	31 Dec 2019
FIRST MANHATTAN CO. LLC.	13F Company 13F	1.5%	$131,174,000 2,068,020 shares	—	31 Dec 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

228

65,790,124

Rows available

228

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2020 Across Filers

Q1 2020 holders

228

Q1 2020 holders

228

Holder diff

Investor	Q1 2020 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q1 2020 value	Value change	Value Chg %